A purity of >99.95% verified by HPLC sets a new commercial benchmark for one of pharma’s most widely used pyrimidine intermediates. Here is what that number means, why it matters, and how it changes the calculus for drug manufacturers worldwide.

By Advance Pharma Chem Technical Team  ·  CAS No. 32779-36-5  ·  Mumbai, India

The Problem with ‘High Purity’

In pharmaceutical manufacturing, the phrase ‘high purity’ has quietly lost its meaning. Walk through any chemical catalogue and you will find the same reassuring claim applied to compounds at 98%, 99%, even 99.5% each one marketed as fit for purpose, each one silently carrying a fraction of a percent of impurities that, in a finished drug product, can mean the difference between a clean regulatory filing and a costly rejection.

For most commodity intermediates, those fractions are acceptable. For pyrimidine-based building blocks used in active pharmaceutical ingredient (API) synthesis where trace impurities can carry through multiple reaction steps and appear in the final molecule they are not.

5-Bromo-2-chloropyrimidine sits squarely in that second category. It is a critical scaffold in the synthesis of antiviral agents, kinase inhibitors, and a growing class of oncology compounds. What goes into the reaction comes out one way or another. Procurement teams and R&D scientists who have spent years navigating the trade-offs between supplier claims and batch-to-batch reality will understand exactly what this means.

Purest 5-Bromo-2-Chloro­pyrimidine

Advance Pharma Chem is pleased to announce that it has achieved a verified purity of greater than 99.95% for 5-Bromo-2-chloropyrimidine (CAS 32779-36-5), as measured by 3 different independent labs. To the best of our knowledge and based on a comprehensive review of commercially available sources, this represents the highest purity of this compound available anywhere in the world.

This is not a laboratory curiosity or a one-batch proof of concept. It is a reproducible, commercially available specification available now for sampling, qualification batches, and bulk supply.

KEY SPECIFICATION
5-Bromo-2-Chloropyrimidine  |  CAS 32779-36-5
Purity: >99.95% by HPLC  ·  Appearance: White to Brown crystalline solid  ·  MW: 193.43 g/mol
Available for: Sampling · Qualification batches · Commercial bulk supply

Why 0.05% Makes a Larger Difference Than It Sounds

Numbers at this level of precision can feel abstract. Consider what they mean in practice.

A purity of 99.5% broadly considered ‘high purity’ in most catalogues means 5,000 parts per million of impurities in every batch you receive. At 99.95%, that figure drops to just 500 parts per million. In a multi-step synthesis leading to a pharmaceutical API, impurities in the starting material do not simply disappear. They can react alongside the intended substrate, generating related-substance impurities in the final product that must then be identified, qualified, and controlled under ICH guidelines.

The downstream consequences of lower-purity starting materials include additional purification steps, increased batch failure rates, extended timelines for impurity profiling, and in the worst cases regulatory questions that delay a filing. For drug manufacturers working under tight development timelines or running continuous manufacturing processes, the starting material specification is not a minor detail. It is a foundational input.

What the >99.95% specification offers, in practical terms, is a cleaner starting point one that compresses development timelines, simplifies impurity management, and gives quality assurance teams fewer variables to control.

Where 5-Bromo-2-Chloropyrimidine Matters Most

5-Bromo-2-chloropyrimidine is a versatile halopyrimidine building block. Its two electrophilic sites the bromine at the 5-position and the chlorine at the 2-position allow for selective, sequential functionalisation, making it a preferred scaffold in:

·  Kinase inhibitor synthesis, including several approved oncology drugs and candidates in late-stage clinical trials

·  Antiviral compound development, where pyrimidine cores serve as key pharmacophores

·  Agrochemical active ingredient synthesis, where consistent purity translates directly to consistent biological performance

·  Early-stage drug discovery programmes, where high-purity building blocks reduce assay noise and improve hit-to-lead confidence

In each of these applications, purity is not a cosmetic specification. It is a performance input. The higher the purity of the starting material, the more predictable and ultimately more efficient the chemistry that follows.

14+ Years in the Making: The Advance Pharma Chem Story

Advance Pharma Chem was established in Mumbai with a single conviction: that the Indian specialty chemicals industry could compete and lead on quality, not just on cost. Over 14 years, the company has built a reputation among global pharmaceutical manufacturers as a supplier that treats specifications as commitments, not approximations.

The 99.95% purity achievement did not happen in a single step. It was the result of 2 years of focused process development on this specific compound iterative refinement of synthesis conditions, purification protocols, and analytical validation, carried out by a team that refused to accept the industry ceiling as its own.

“We knew the industry standard was not good enough for the applications our customers were targeting. We set ourselves a target that most said was unnecessary. It took 2 years, but achieving it changes what we can offer the world.”
— Adwait Gokhale, Partner, Advance Pharma Chem

The company’s ISO-compliant facility in Mumbai supports production at both development and commercial scale, with a quality system designed to deliver the same specification batch after batch not just in the first qualification run, but across every order.

Rigorous Testing: What >99.95% Actually Means Analytically

The purity claim is supported by HPLC analysis the gold standard for quantitative purity determination in pharmaceutical intermediates. HPLC separates individual components of a sample by their interaction with a stationary phase, providing precise quantification of both the principal compound and any co-eluting impurities. At purity levels above 99.9%, the analytical method itself requires careful validation to ensure that the measurement is meaningful rather than merely impressive.

Commercially available alternatives for 5-bromo-2-chloropyrimidine typically carry HPLC-verified purities in the range of 97% to 99.5%. The gap between 99.5% and 99.95% may appear small in percentage terms. In parts-per-million impurity content, it is an order of magnitude difference. For regulated pharmaceutical manufacturing, that difference is material.

Full Certificate of Analysis documentation is available upon request, including detailed impurity profiles. Customers undertaking supplier qualification exercises are encouraged to request a sample batch for independent analytical verification we welcome scrutiny at this level of performance.

What This Means for Your Manufacturing Operation

For procurement and sourcing teams, a higher-purity starting material from a qualified supplier represents a direct input into supply chain risk management. Fewer batch failures. Fewer out-of-specification investigations. A more predictable yield profile and a tighter impurity budget at the API stage.

For R&D teams, working with >99.95% purity from the earliest stages of a programme means that the chemistry you develop at the bench will translate more faithfully to the process you scale. Variables introduced by starting material quality are eliminated early before they become embedded in a manufacturing process that is difficult and expensive to change.

For regulatory affairs, higher starting material purity simplifies the impurity justification narrative in a drug master file or marketing authorisation application a benefit that may not show up on a cost-per-kilogram comparison but becomes very visible when a regulatory question is raised six months before a planned submission.

Setting a New Standard

The pharmaceutical industry is in the business of precision. The molecules it makes are measured in nanograms. The trials it runs are measured in years. The standards it sets are measured against what is possible not merely what is convenient. Advance Pharma Chem believes that the materials which go into those molecules deserve the same level of ambition.

Achieving >99.95% purity for 5-Bromo-2-Chloropyrimidine is not the end of that ambition. It is a demonstration of what 14 years of focused expertise in specialty pharmaceutical intermediates makes possible and a signal of what customers can expect from every compound in our portfolio.

The standard has been set. We invite you to verify it yourself.

REQUEST A SAMPLE
5-Bromo-2-Chloropyrimidine  ·  CAS 32779-36-5  ·  Purity >99.95% HPLC
Contact us at [email protected] ·  www.advancepharmachem.in